Legal Alliance Company informs of a legal services contract agreement with the pharmaceutical company GlaxoSmithKline in Ukraine.
Illya Kostin, partner with the Legal Alliance commented on the event in the following order: ”We are grateful to the colleagues at GlaxoSmithKline for appreciating our experience and in-depth specialization in the sphere of legal regulations of the pharmaceutical business. We will try to not only justify the trust bestowed onto our team but to exceed it”.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
